Clinical features of anti-TIF1- antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1- or anti-Mi-2 autoantibodies-Reference-Cited by-同舟云学术

Clinical features of anti-TIF1- antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1- or anti-Mi-2 autoantibodies

Published:2012-04-25 Issue:8 Volume:51 Page:1508-1513
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Muro Y.,Ishikawa A.,Sugiura K.,Akiyama M.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/51/8/1508/5216107/kes073.pdf

Reference18 articles.

1. Dermatomyositis and polymyositis

2. Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis

3. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy

4. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis

5. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TIF1-γ Positive Dermatomyositis with Spontaneous Muscular Hematoma in the Context of Ovarian Cancer: A Novel Survival Case Report;Journal of Inflammation Research;2024-06

2. Causality Assessment Between Idiopathic Inflammatory Myopathies and Lung Cancer;JCR: Journal of Clinical Rheumatology;2024-02-14

3. A case of juvenile amyopathic dermatomyositis with anti‐transcription intermediary factor 1‐α antibody showing negative anti‐TIF1 ‐γ ELISA results: Comment on “Case of pembrolizumab‐induced dermatomyositis with anti‐transcription intermediary factor 1‐γ antibody”;The Journal of Dermatology;2022-09-29

4. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large‐scale cohort study in China;Cancer Communications;2022-03-31

5. NanoString technology distinguishes anti‐TIF‐1γ + from anti‐Mi‐2 + dermatomyositis patients;Brain Pathology;2021-05